Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Docosahexaenoic acid - Martek Biosciences

Drug Profile

Docosahexaenoic acid - Martek Biosciences

Alternative Names: ARASCO; DHA - Martek Biosciences; DHA GOLD; DHASCO; Formulaid; Life'sDHA; Neuromins

Latest Information Update: 23 Apr 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Martek Biosciences
  • Developer Martek Biosciences; National Institutes of Health (USA)
  • Class Antihyperlipidaemics; Docosahexaenoic acids; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Nutrition disorders
  • No development reported Alzheimer's disease
  • Discontinued Breast cancer; Colorectal cancer; Hyperlipidaemia; Malignant melanoma

Most Recent Events

  • 23 Apr 2015 No recent reports of development identified - Phase-III for Alzheimer's disease in USA (PO)
  • 22 Feb 2011 DSM acquires Martek Biosciences
  • 02 May 2007 Preclinical data added to the Alzheimer's Disease and Cognition Disorders pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top